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Repeated inoculation of mice, monkeys, and humans with x-irradiated sporozoites 
can  lead  to sterile immunity against  malarial  infection  (1,  2),  Vaccinated  animals 
have serum antibodies capable of neutralizing sporozoites (3)  and of reacting with 
their surface membranes (4, 5). Exposure of humans to infected mosquitoes in endemic 
areas  leads  to  the  development  of relatively  high  serum  titers  of antisporozoite 
antibodies  (6).  Upon incubation with immune serum, viable sporozoites develop at 
their posterior end a  thread-like precipitate which  increases progressively in length 
(circumsporozoite precipitation [CSP] 1 reaction [7]). 
To  clarify  the  nature  of the  antibody-parasite  interaction  and  its  relation  to 
protective immunity, we recently used the technique of KiJhler and  Milstein  (8)  to 
obtain  hybrid cells between  a  plasmacytoma  line and  spleen  cells  from  mice  that 
produced antibodies  to surface antigens of Plasmodium berghei. One clone of hybrid 
cells produced antibodies against a protein with an apparent 44,000 mol wt  (Pb44), 
which  envelops  the  surface  membrane  of sporozoites.  In  vitro  incubation  of the 
parasites with these antibodies abolished their infectivity (9). 
In  this  paper,  we  study  the  effects  of this  antibody  and  of its  fragments  on 
sporozoites in vitro and their protective effects in vivo against malarial infection. 
Materials and Methods 
Media and Reagents.  Phosphate-buffered  saline (PBS), Dulbecco's modified Eagle's medium 
(DMEM),  antibiotic-antimycotic solution,  horse  serum,  and  fetal calf serum,  were obtained 
from Grand  Island  Biological Co., Grand  Island,  N.  Y.  Medium  199  and  RPMI-1640  were 
obtained  from Microbiological Associates, Walkersville, Md.  Hypoxanthine  (H), aminopterin 
(A), thymidine (T), Hepes  (sodium salt),  and dimethyl sulfoxide were obtained from Sigma 
Chemical  Co.,  St.  Louis, Mo.  Polyethylene glycol-1000 was obtained from the J.  T.  Baker 
Chemical  Co;  Phillipsburg,  Pa.  Pristane  was  obtained  from  Aldrich  Chemical  Co.,  Inc., 
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Milwaukee,  Wis.;  MOPC-21,  IgGl  myeloma  protein  was  obtained  from  Litton  Bionetics 
Laboratory Products, Kensington, Md.;  and  agarose  (Seakem;  Marine Colloids, Inc.,  Div., 
FMC Corp., Rockland, Maine). DEAE-Sephadex A-50 and Sephadex G-200 were obtained 
from Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J. 
The chemicals for sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) 
were  obtained  from  the  following  sources:  N,N'-methylene-bis-acrylamide,  acrylamide, 
N,N,N',N'-tetramethylene  diamine, and  ammonium  persulfate from  Bio-Rad Laboratories, 
Richmond, Calif.; X-omat R  film XR5 was obtained from Eastman Kodak Co., Rochester, 
N.Y. 
Antisera.  Fluorescein-conjugated rabbit anti-mouse IgG was purchased from Meloy Labo- 
ratories Inc., Springfield, Va. A  rabbit antiserum to mouse a- and K-chains was prepared by 
injection of purified myeloma protein and was a gift from Dr. Michael E. Lamm, New York 
University School of Medicine, New York. Specific antisera to mouse IgG1 and to mouse g- 
chains were purchased from Litton Bionetics Laboratory Products. 
Animals.  Female mice of the BALB/c and A/J strains were obtained from The Jackson 
Laboratory, Bar Harbor, Maine. 
Purification of Sporozoites, Radiolabeling, and Preparation of Extracts.  Sporozoites of P. berghei (NK 
65 strain) were obtained from Anopheles stephensi mosquitoes 15-18 d after their infective blood 
meal (10). The purification procedure, the radiolabeling of cell membranes with 125I, and the 
preparation of extracts are described elsewhere (9).  Sporozoites of Plasmodium yoelii nigeriensis, 
Plasmodiumyoeliiyoelii, and Plasmodium chabaudi, which originated from mosquitoes fed on mice 
infected with  isolates of the  blood  stage of the  parasites, was  kindly provided  by  Dr.  D. 
Wallicker, University of Edinburgh, Edinburgh, Scotland. 
CSP  Reactions.  Sporozoites  were  incubated  at  37°C  for  30  rain  in  Medium  199  that 
contained 10% normal mouse serum or in a  dilution of antibodies in the same medium. The 
morphological changes in the parasites were followed under a  Zeiss microscope (Carl Zeiss, 
New York) (magnification: ×  400, phase objective). 
Immunization of Mice.  P. berghei sporozoites were given to anesthetized BALB/c mice once a 
week  by  bite  of y-irradiated infected  mosquitoes  according  to  the  method  described  by 
Vanderberg et al. (11). The animals were used after the sixth booster, when they had developed 
high CSP titers and were protected against sporozoite challenge. 
Production of Hybridoma.  We used the method  described by K~ihler and  Milstein (8)  and 
Pontecorvo  (12)  with  minor modifications. The  whole  procedure was carried out  at  room 
temperature. Spleen cells from BALB/c mice immunized with P. berghei were obtained 4 d after 
the last booster. 1.4 ×  108 washed spleen cells and 1.4 ×  107 plasmacytoma cells (P3U1, kindly 
given to us by Dr. J. Unkeless, The Rockefeller University, New York) were used for fusion. 
After they were mixed, the cells were washed once by centrifugation in a conical glass tube with 
~20 ml of DMEM that contained 20 mM Hepes buffer, pH 7.2, in serum-free medium (200 g 
for  10  min).  The  pellet was resuspended gently in  1 ml  of a  solution that  contained  35% 
polyethylene glycol 1000,  5% dimethyl sulfoxide in RPMI-1640 medium. Immediately after- 
wards, the cells were further diluted by adding, in succession, 3  ml of DMEM  in  ~3  min, 
followed by 12 ml of DMEM with 20% horse serum in ~5 min. The tube was rotated slowly 
during this procedure. Subsequently, the cell suspension was centrifuged at 200 g for 10 min 
and  resuspended  in  50  ml  of DMEM  that  contained  10%  fetal calf serum,  1%  antibiotic- 
antimycotic solution, 3 ×  10  -4 M  of T], and  10  -s M  of H  (DMEM-HT complete medium). 
The suspension was distributed in aliquots of ~50/LI per well in 96-well plates (Linbro Chemical 
Co., Hamden, Conn.) 24 h later, another 50/~1 of DMEM-HT complete medium plus 10  -5 M 
A were added to each well. Supernates were tested for the presence of antibodies to sporozoites 
by indirect immunofluorescence. 
Purification of Monoclonal Antibodies and Preparation of Fab Fragments.  Ascites was induced by 
intraperitoneal inoculation of hybrid cells into BALB/c mice previously injected with pristane. 
100 ml of ascitic fluid that contained ~2 mg/ml of antibodies to Pb44 were dialyzed against 
0.01 Tris-HCI buffer, pH 8.6, that contained 0.02 M  NaCI (conductivity 1.6 mS at 0°C). After 
centrifugation at  10,000 g for 30 min, the supernate was loaded onto a  2.5- ×  30-cm column 
that contained DEAE-Sephadex A-50 equilibrated in the same buffer. The column was washed 
extensively with the starting buffer until the OD at 280 nm of the eluate was <0.050. A linear 1506  MONOCLONAL ANTIBODIES AGAINST MURINE  MALARIAL INFECTION 
NaCl gradient (to  12 mS) was then applied. The monoclonal antibodies eluted in a sharp peak 
in  tubes  with  conductivities  close  to  5  mS.  These  fractions  were  pooled,  concentrated,  and 
subjected to molecular-sieve chromatography  in Sephadex G-200.  The antibody  activity was 
associated  with  the  material  eluted  in  the  first  OD peak.  About  100  mg of antibodies  were 
recovered.  The  antibodies  were  digested  with  papain  to  prepare  Fab  fragments  using  the 
method described by Nisonoff (13).  The digestion was stopped  by addition of excess iodoacet- 
amide and  the antibody  fragments  were further purified  by molecular-sieve chromatography 
on  Sephadex  G-200.  No intact  antibodies  were present  in  the  Fab  preparation  as  shown  by 
SDS-PAGE (Fig.  1). 
Immunoprecipitation.  Immunoprecipitation was performed as described by Kessler (14)  using 
a  suspension  of formaldehyde-treated  Staphylococcus aureus, Cowan  I  strain  (Staph  A)  to  bind 
immune complexes. The monoclonal antibodies to Pb44 are of the IgG 1 subclass  (Results). For 
this reason, and  to enhance the binding of complexes to Staph  A, all reactions and  washings 
were carried out in Tris-buffer at pH 8.6  (15).  Eluates from the bacteria in sample buffer that 
contained 2% SDS,  10% glycerol, and  5% fl-2-mercaptoethanol  in 0.08 M  Tris-buffer, pH 6.8, 
were loaded on SDS-PAGE slab gels. 
SDS-PAGE.  SDS-PAGE was performed in slabs as described by Laemmli (16). The stacking 
and  separating  gel combinations  used  were 5  and  7.5%.  To calibrate  the  gels  for molecular 
weight  estimation,  we  used  proteins  from  a  kit  purchased  from  Pharmacia  Fine Chemicals, 
Fie.  1.  Characterization of purified monoclonal antibodies to Pb44 and its papain digest. On the 
left are results of high-voltage electrophoresis  in agarose of ascitic  fluid from a mouse that bore the 
hybridoma tumor (track b), and the purified monoclonal antibodies to Pb44  (track a). On the right, 
SDS-PAGE under reducing conditions of the native monoclonal antibodies (tracks c and f), and of 
the papain digest  (tracks d and e). Notice that the tracks that contained the digest were overloaded 
to  verify  the  absence  of intact  heavy  (H)  chains.  These  tracks  show  heavy-chain  fragments  in 
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Div. of Pharmacia, Inc. (range of molecular weights from 14,400 to 94,000). After electropho- 
resis, the gels were stained with 0.04% Coomassie blue in  10% methanol and 7% acetic acid. 
Destaining  was carried out with a 30% methanol, 7% acetic acid solution.  Photographs of the 
stained gels were obtained after drying. Radioautography was carried out by exposing the dried 
gels to an X-omat R  film (XRS)  and an image-intensifying  screen  (Cronex;  DuPont Instru- 
ments, Wilmington, Del.) at -70°C. 
Agarose Electrophoresis.  Agarose electrophoresis  was performed in  l-mm thick agarose  gel 
(1.1%) in veronal buffer, pH 8.6, as described by Johansson (17). 
Results 
Isolation and Characterization of Monoclonal Antibodies  to Pb44.  There was significant 
growth of cell colonies in 575 out of 859 wells seeded after fusion of the plasmacytoma 
cell line with spleen cells from mice immunized with P. berghei sporozoites. Five wells 
yielded supernates that  contained antibodies to sporozoites as detected by indirect 
immunofluoreseence.  Only  one  (3Dll)  however,  was  successfully  expanded  and 
cloned by the  limiting-dilution  method.  We used  thymocytes from adult  BALB/c 
mice (10  e cells per well) as feeder cells during cloning. Out of six clones tested, five 
were positive by immunofluorescence. These five supernates were used to immuno- 
precipitate extracts of lzSI-surface-labeled sporozoites of P. berghei by the Kessler (14) 
procedure. As shown in Fig. 2, all reacted against Pb44. 
Monoclonal antibodies to Pb44 were isolated from the ascitic fluid of mice that 
bore the hybridoma tumor and analyzed by high-voltage agarose-gel electrophoresis 
and by double diffusion using specific antisera to mouse immunoglobulin heavy and 
light chains. We characterized the antibodies as fl-globulins containing ),1, x  chains. 
Protective Effects  of Antibodies  to  Pb44.  The  first  indication  that  the  monoclonal 
antibodies to Pb44 had a  protective effect in vivo came from experiments in which 
mice that bore the hybridoma, but not the parent plasmacytoma, were resistant  to 
malaria, i.e., they failed to develop infection upon challenge with 2.5 ×  104 sporozoites 
(Table I). 
To establish  that  indeed the antibodies  secreted by the  tumor  were preventing 
infection, several  groups of A/J  mice were  injected  intravenously with  decreasing 
amounts of purified antibody, and they were challenged with sporozoites 30 rain later. 
In  mice challenged with  103 sporozoites, almost  complete protection was obtained 
with  the  smallest  doses  of antibody  used  (10-50  #g).  In  animals  receiving  104 
sporozoites, only the highest  dose of antibody (300 #g)  was  fully protective. In all 
groups that received antibody and in which parasitemia was observed, the prepatent 
period was prolonged in relation to controls (Table II). 
To clarify the mechanism of the antibody-mediated protection, we compared the 
effects on sporozoites of Fab fragments and intact antibodies. Because the fragments 
and native molecules have very different clearance rates (18), we used the sporozoite- 
neutralizing  test  for  this  comparison.  P.  berghei sporozoites  were  incubated  with 
different concentrations of the reagents for 45 min at room temperature and injected 
into mice. The results (Table III) showed that Fab and the intact antibody are almost 
equally effective in their neutralizing activity. 
That the effect of Fab fragments on sporozoites was specific is shown by the lack of 
neutralizing activity of the same preparation on sporozoites of P. yoelii nigeriensis, a 
different species of rodent malaria.  Also, P.  berghei sporozoites incubated in Fab  (1 
mg/ml) prepared from nonspecific rabbit gamma globulin remained fully infective. 1508  MONOCLONAL ANTIBODIES AGAINST MURINE  MALARIAL INFECTION 
FiG.  2.  SDS-PAGE of immunoprecipitates resulting from the reaction of labeled sporozoites  with 
supernates  from  cultured  clones  of hybridoma  cells.  The  surface  membrane  of sporozoites  was 
radiolabeled with 12sI and solubilized  in detergent. Portions of the labeled extracts were incubated 
with culture fluids  from wells that contained clones  of hybridoma cells. The immune complexes 
were bound to Staph A, eluted with sample buffer that contained denaturing and reducing agents, 
and loaded in the gel. Shown are the results  of the radioautography of the dried gel. Tracks 2-6 
originate from immunoprecipitation with supernates  from five different clones. Tracks  1 and 7 are 
controls  obtained  after immunoprecipitation  of the extracts  with  normal  mouse serum  or with 
MOPC-21 myeloma protein (IgGl, x), respectively.  Note that a single specific band was immuno- 
precipitated by  the supernates  derived from  the clones  (Pb44).  The apparent  molecular weight 
(42,000-44,000) was determined by comparison of its electrophoretic mobility with that of standards 
of known  molecular weights. 
The Mechanism of the  CSP Reaction.  Next  we  investigated  the  role  of Pb44  in  the 
CSP  reaction.  As  shown  in  Table  IV,  monoclonal  antibodies  at  concentrations 
between  10  and  20/xg/ml  induce  the tail-like precipitate  at  the posterior  end  of the 
viable sporozoite.  The  reaction  is specific:  no  morphological  changes  were  observed 
upon  incubation  of P. yoelii  yoelii, P. yoelii nigeriensis or P. chabaudi sporozoites with the 
antibodies.  Fab  fragments  of  antibodies  to  Pb44  alone  were  totally  ineffective  in 
inducing CSP  reactions,  even at  high concentrations  (1,500/xg/ml).  However, strong 
CSP  reactions  occurred  if, after  incubation  with low concentrations  of Fab  (1-2/xg/ 
ml),  the  sporozoites  were  treated  with  rabbit  antibodies  to  mouse  x-chains.  The 
binding  of Fab  to the surface  membrane  of the parasite  could  also be demonstrated 
by indirect  immunofluorescence. P.  POTOCNJAK,  N.  YOSHIDA,  R.  NUSSENZWEIG,  AND  V.  NUSSENZWEIG 
TABLE  I 
Mice That Bear the Hybridoma  Tumor 31911  Are Resistant to Infection  with 
P. berghei Sporozoites 
Experiment  Tumor cells injected* 
Result of chal- 






Hybridoma 3D 11 anti-Pb44  0/10 
Plasmacytoma P3U 1  3/4 
None  5/5 
Hybridoma 3DI 1 anti-Pb44  0/10 
Plasmacytoma P3UI  4/5 
None  4/5 
* Solid tumors were induced in BALB/c mice by subcutaneous injection of 
5 ×  10Scells.  2 wk later, when the tumors were ~1 cm in diameter, the mice 
were challenged with 5 ×  1Da or 25 ×  ID  a sporozoites in experiments I and 
II, respectively. 
TABLE  II 
Resistance  to Infection  with P. berghei Sporozoites of Mice Injected with Purified Monodonal 
Antibodies  to Pb44* 
1509 
Challenged with 10  a sporozoites  Challenged with 104 sporozoites 
Dose of anti-  Number in-  Number in-  bodies  fected/Number  Prepatent period  fected/Number 
challenged  challenged 
Prepatent period 
Ilg/mouse  d ±  SE  d ±  SE 
300  0/5  --  0/5  -- 
100  0/5  --  4/5  5.7 ±  0.2 
50  1/5  7.0  5/5  5.2 ± 0.2 
25  1/5  6.0  5/5  5.2 ± 0.2 
10  0/5  --  5/5  4.6 ±  0.4 
None  5/5  5.2 ±  0.4  5/5  4.0 ±  0 
* Purified antibody was administered intravenously to A/J mice 30 min before challenge 
with either IDa or 104 sporozoites. 
Discussion 
Our findings demonstrate that monospecific antibodies (IgG1, r)  directed against 
a  surface component  (Pb44)  of P.  berghei sporozoites confer complete protection to 
mice against an otherwise lethal inoculum of parasites. The degree of protection is a 
function  of the  number  of parasites  used  in  the  challenge  and  of the  antibody 
concentration. Mice that bore the hybridoma tumor, whose serum concentration of 
antibodies to Pb44 was ~2 mg/ml, were completely protected against infection with 
2.5 ×  104 sporozoites (Table I). Passive transfer of relatively small amounts of antibody 
(10 pg) abolished or profoundly diminished the infectivity of 103 parasites, but much 
greater amounts of antibody (300 pg) were required for complete protection against 
challenge with  104 sporozoites. The effects of antibody were also clearly reflected in 1510  MONOCLONAL  ANTIBODIES  AGAINST  MURINE  MALARIAL  INFECTION 
TABLE  III 
Neutralization of P. berghei by Treatment In  Vitro with Monoclonal Antibodies 
to Pb44 or Their Fab Fragments* 
Treatment with anti-Pb44  Result of chal- 
lenge of mice;  Parasite 
number infected/ 






1,200  --  0/i0 
240  --  3/15 
48  --  5/10 
24  --  3/5 
12  --  4/5 
--  1,200  0/15 
--  240  0/15 
--  48  0/9 
--  24  5/5 
--  12  5/5 
Control:[:  19/20 
P. yoelii nigeriensis  --  1,200  5/5 
P. yoelii nigeriensis  Control:l:  5/5 
* l0  b sporozoites were incubated for 45 rain at room temperature with native 
monoclonal  antibodies  to  Pb44  or  Fab  fragments in  0.5  ml  of PBS  that 
contained  10%  of normal  mouse serum. After  incubation,  104 sporozoites 
were injected intravenously into each A/J mouse. The table summarizes the 
results of three separate experiments. 
~: No antibody. 
TABLE  IV 
P. berghei CSP Reactions Induced by Monoclonal Antibodies to Pb44 and by 
Their Fab Fragments 
CSP titer* 
Reagent 
Direct  Indirect 
Ig anti-Pb44  1/128  -- 
Fab anti-Pb44  Negative  l / 1,024 
Medium (control):~  Negative  Negative 
* Maximal  dilution  of antibodies  or  Fab  fragments giving a  positive  CSP 
reaction as described in Materials and Methods. The initial concentrations 
of native  antibody  and  Fab  fragments were  identical  (1.5  mg/ml).  After 
incubation with the Fab dilutions or with medium (control), the sporozoites 
were washed once with Medium  199 and reincubated for an additional  30 
minutes with 50/~1 of a  1/10 dilution of a rabbit antiserum to mouse x-chains 
(indirect CSP reaction). 
~Controls  were  incubated  with  Medium  199  that  contained  10%  normal 
mouse serum. 
the  significant  prolongation  of  the  prepatent  periods  in  all  animals  that  became 
infected  (Table  II).  Taking  into  consideration  that  a  small  number  of  parasites  is 
usually  injected  by  mosquito  bite  (19),  our  findings  are  encouraging  for  the  prospect 
of developing  a  malaria  vaccine  using  purified  sporozoite  membrane  antigens. P.  POTOCNJAK, N. YOSHIDA, R.  NUSSENZWEIG, AND V. NUSSENZWEIG  1511 
It should be pointed out, however, that mice actively immunized by the injection 
of radiation-attenuated sporozoites are fully protected against  challenge with up to 
105 sporozoites, and may have relatively low antibody titers, as determined by CSP 
reactions (20). The reason for the greater effectiveness of the vaccine as compared to 
passive administration of antibodies to Pbzl4 is not clear. It is possible that protection 
in vaccinated mice is mediated by antigens other than Pb44. Alternatively, antibodies 
to Pb44 of other classes and/or of other specificities with higher binding affinity may 
be present  in the  vaccinated mice, and  these may be more efficient in protection. 
(The present hybridoma is of the IgG1 subclass, which presumably does not activate 
the classical complement pathway  [21].)  Also, in  actively immunized  animals,  the 
protective role of antibodies is probably enhanced by cellular mechanisms.  Some of 
these  questions  may hopefully be  answered  by developing and  characterizing the 
properties of additional  monoclonal antibodies  to  P.  berghei, and  by studying the 
protective effects of vaccination with purified Pb44. 
The  neutralizing  activity of antibodies  to  Pb44  may be  mediated  through  the 
primary interaction, that is, an effect on the parasite itself and/or could result from 
secondary effects such as complement fixation, phagocytosis, killer-cell activity, etc. 
The finding that Fab fragments are as effective in mediating protection as the native 
molecule (Table III)  strongly suggests that  the antibodies  interfere with a  parasite 
function necessary for its infectivity, such as, for example, the ability to penetrate into 
the target cell or to proliferate in the hepatocytes after penetration. 
Our observations also shed light on the nature of the CSP reaction. This reaction, 
which consists of the formation of a thread-like precipitate at the posterior end of the 
sporozoites  (4,  7)  occurred after direct interaction of the parasites  with  the  intact 
monoclonal antibody to Pb44. The monovalent (Fab) antibody fragments alone, even 
at  very  high  concentrations,  were  ineffective, but  the  reaction  could  be  readily 
produced  by  treating  sporozoites  with  small  concentrations  of Fab  followed  by 
incubation  with  rabbit  antibodies  to  mouse K-chains.  We conclude that  the  CSP 
reaction can result from the cross-linking of Pb44 and that its characteristics are those 
of a capping reaction followed by shedding of the immune complexes (22). 
The significance of the CSP reaction is not clear. It could represent a  mechanism 
of escape of the  parasite  from the host  immune response.  The efficacy of such  an 
escape mechanism  is questionable.  The antigen-antibody complexes formed on the 
surface of the sporozoites remain fully accessible to effector mechanisms which would 
tend to eliminate the parasites. Moreover, our data show that the CSP reaction does 
not  protect  the  parasite,  but  rather  the  host,  because  at  high  concentrations  of 
antibody, when  the CSP  reaction is strongest,  sporozoite challenge  fails  to  induce 
infection. 
An  intriguing  possibility is  that  the CSP  reaction mimics the events that  occur 
when the parasites encounter the target cell. In other words, the antibodies to Pb44 
could be artificially triggering a  reaction, which under normal circumstances would 
take place when Pb44 molecules encounter an appropriate divalent receptor on the 
membrane of the target cells, presumably hepatocytes. Perhaps by binding to Pb44, 
antibodies  would  render  these  molecules  inaccessible  to  the  putative  hepatocyte 
receptor and thus interfere with sporozoite infectivity. 
We are currently using  the  monoclonal antibodies  to  purify Pb44  to  determine 
whether  the  isolated  protein  is  immunogenic  and  can  be  used  as  a  vaccine.  If 1512  MONOCLONAL  ANTIBODIES  AGAINST MURINE MALARIAL INFECTION 
successful,  this  would  encourage  similar  attempts  to  characterize  and  isolate  the 
protective antigen(s)  of sporozoites of human malaria. 
Summary 
Monoclonal antibodies (IgG 1, I¢) directed against a surface component of Plasmodium 
berghei sporozoites (Pb44) confer complete protection to mice against a lethal inoculum 
of parasites. The degree of protection is a  function of the number of parasites used in 
the challenge and of the antibody concentration in serum. Passive transfer of 10 #g of 
antibody per mouse abolished or profoundly diminished  the infectivity of 103 sporo- 
zoites, but much higher amounts of antibody were required  for complete protection 
against challenge with  104 parasites. 
Fab fragments of the monoclonal antibodies were as effective as the intact antibodies 
in  mediating  protection  as  determined  by the  neutralizing  assay.  This  observation 
suggests  that  the  antibodies  interfere  with  a  parasite  function  necessary  for  its 
infectivity,  such  as,  for example,  the  ability  to  penetrate  into  the  target  cell  or  to 
multiply in the hepatocytes. 
When sporozoites are incubated with the intact  monoclonal antibodies at 37°C, a 
long  filament  appears  at  its  posterior  end  (circumsporzoite  precipitation  [CSP] 
reaction).  Fab  fragments  are  ineffective  at  high  concentrations.  However,  if after 
treatment  with  Fab,  the sporozoites are incubated  with  rabbit  antibodies  to mouse 
K-chains, a  strong CSP reaction is observed. We conclude that the CSP reaction can 
result  from the cross-linking of Pb44 and that  it has the characteristics  of a  capping 
reaction followed by the shedding of the immune complexes. 
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